deoxyglucose has been researched along with Parkinson Disease in 51 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (23.53) | 18.7374 |
1990's | 32 (62.75) | 18.2507 |
2000's | 3 (5.88) | 29.6817 |
2010's | 3 (5.88) | 24.3611 |
2020's | 1 (1.96) | 2.80 |
Authors | Studies |
---|---|
Hatanaka, Y; Ikuno, M; Isa, K; Isa, T; Murayama, S; Okuda, S; Onoe, H; Sawamura, M; Takahashi, R; Tsukada, H; Uemura, N; Yamakado, H | 1 |
Bastide, MF; Bézard, E; Boraud, T; de la Crompe, B; Doudnikoff, E; Fernagut, PO; Gross, CE; Mallet, N | 1 |
Chaudhuri, AD; Choi, DC; Junn, E; Kabaria, S; Mouradian, MM | 1 |
Bae, ON; Chung, JH; Chung, SM; Kim, HH; Kim, HY; Kim, KY; Kim, SH; Lim, KM; Noh, JY; Shin, S | 1 |
Bolner, A; De Riva, V; Nordera, GP; Pilleri, M | 1 |
Cole, NB; Dieuliis, D; Leo, P; Mitchell, DC; Nussbaum, RL | 1 |
Wagner, HN | 1 |
Kuhl, DE; Markham, CH; Metter, EJ; Riege, WH | 1 |
Kameyama, M; Kuhl, DE; Metter, EJ; Phelps, ME; Riege, WH | 1 |
Agid, Y; Baron, JC; Bustany, P; Collard, P; Comar, D; Rougemont, D | 1 |
Kuhl, DE; Metter, EJ; Riege, WH | 2 |
Antonini, A; Günther, I; Leenders, KL; Maguire, PR; Missimer, J; Psylla, M; Vontobel, P | 1 |
Belakhlef, A; Chaly, T; Dhawan, V; Eidelberg, D; Fahn, S; Ishikawa, T; Mandel, F; Moeller, JR; Przedborski, S; Spetsieris, P | 1 |
Bressi, S; Caraceni, T; Cortelli, P; Fazio, F; Gentrini, S; Grassi, F; Perani, D; Savoiardo, M; Testa, D | 1 |
Chaly, T; Dahl, JR; Dhawan, V; Eidelberg, D; Ishikawa, T; Margouleff, D; Moeller, JR; Robeson, W; Spetsieris, P | 1 |
Chaly, T; Dhawan, V; Eidelberg, D; Fahn, S; Giladi, N; Ishikawa, T; Przedborski, S; Spetsieris, P; Takikawa, S | 1 |
Andrén, PE; Gunne, LM | 1 |
Fieschi, C; Morelli, M; Orzi, F; Pontieri, FE | 1 |
Kumar, A | 1 |
Dhawan, V; Eidelberg, D; Fahn, S; Giladi, N; Goldman, S; Hildebrand, J; Przedborski, S; Takikawa, S | 1 |
Chaly, T; Dahl, JR; Dhawan, V; Eidelberg, D; Fazzini, E; Margouleff, D; Moeller, JR; Redington, K; Robeson, W; Takikawa, S | 1 |
Beric, A; Dhawan, V; Dogali, M; Eidelberg, D; Fazzini, E; Ishikawa, T; Moeller, JR; Silbersweig, D; Spetsieris, P; Stern, E; Woods, RP | 1 |
Alexander, GE; Dhawan, V; Eidelberg, D; Grady, C; Ishikawa, T; Mandel, F; Moeller, JR; Pietrini, P; Spetsieris, P | 1 |
Hirato, M; Horikoshi, S; Ishihara, J; Ohye, C; Shibazaki, T | 1 |
Albin, RL; D'Amato, CJ; Frey, KA; Kuhl, DA; Minoshima, S; Sima, AA | 1 |
Antonini, A; Boecker, H; Conrad, B; Grafin von Einsiedel, H; Kruggel, F; Kuwert, T; Leenders, K; Weindl, A | 1 |
Akiguchi, I; Fukuyama, H; Hanakawa, T; Kato, M; Kimura, J; Shibasaki, H | 1 |
Giordani, B; Koeppe, RA; Kuhl, DE; Minoshima, S; Piert, M | 1 |
Brooks, DJ; Morrish, PK; Sawle, GV | 1 |
Shibasaki, T | 1 |
Arahata, Y; Kato, T; Sobue, G; Tadokoro, M | 1 |
Bönner, H; Ghaemi, M; Heiss, WD; Herholz, K; Holthoff-Detto, VA; Kessler, J; Pietrzyk, U; Wagner, R; Wienhard, K; Würker, M | 1 |
Albin, RL; Berent, S; Foster, NL; Frey, KA; Giordani, B; Koeppe, RA; Kuhl, DE; Minoshima, S; Vander Borght, T | 1 |
Bezard, E; Brotchie, JM; Crossman, AR; Gross, CE | 1 |
Fukumura, T; Goto, I; Hosokawa, S; Ichiya, Y; Kato, M; Kuwabara, Y; Masuda, K; Otsuka, M; Sasaki, M | 1 |
Ito, K; Kato, T; Kume, A; Sakuma, S; Shiratori, M; Tadokoro, M; Takahashi, A | 1 |
Heiss, WD; Herholz, K; Holthoff, V; Huber, M; Karbe, H; Wagner, R; Wienhard, K | 1 |
Snow, BJ | 1 |
Boyce, S; Crossman, AR; Mitchell, IJ; Sambrook, MA | 1 |
Moeller, JR; Strother, SC | 1 |
Cedarbaum, J; Dhawan, V; Eidelberg, D; Fahn, S; Ginos, JZ; Greene, P; Moeller, JR; Rottenberg, DA; Sidtis, JJ; Strother, SC | 1 |
Kato, M | 1 |
Boyce, S; Clarke, CA; Crossman, AR; Robertson, RG; Sambrook, MA | 1 |
Crossman, AR | 1 |
Calne, DB; Okada, J; Peppard, R | 1 |
Alavi, A; Alavi, J; Chawluk, J; Dann, R; Kushner, M; Reivich, M | 1 |
Hayden, MR; Martin, WR | 1 |
Adam, MJ; Ammann, W; Bergstrom, M; Harrop, R; Laihinen, A; Martin, WR; Rogers, JG; Ruth, TJ; Sayre, CI; Stoessl, AJ | 1 |
Kuhl, DE; Markham, CH; Mazziotta, JC; Metter, EJ; Phelps, ME; Riege, WH | 1 |
Battistin, L; Bracco, F; Dam, M; Pizzolato, G; Rigo, A | 1 |
8 review(s) available for deoxyglucose and Parkinson Disease
Article | Year |
---|---|
Metabolic mapping of the pharmacological and toxicological effects of dopaminergic drugs in experimental animals.
Topics: Animals; Brain; Brain Mapping; Carbon Radioisotopes; Central Nervous System Stimulants; Deoxyglucose; Dopamine Agents; Parkinson Disease; Radionuclide Imaging | 1993 |
Functional brain imaging in late-life depression and dementia.
Topics: Age Factors; Aged; Brain; Dementia; Dementia, Vascular; Deoxyglucose; Depressive Disorder; Diagnosis, Differential; Glucose; Humans; Middle Aged; Parkinson Disease; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1993 |
[Glucose metabolism and blood flow studies in 2 cases with juvenile Parkinson's disease].
Topics: Adult; Age of Onset; Brain; Cerebrovascular Circulation; Deoxyglucose; Female; Fingers; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Movement; Parkinson Disease; Rest; Tomography, Emission-Computed | 1997 |
[18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease].
Topics: Brain; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Parkinson Disease; Tomography, Emission-Computed | 1997 |
Positron emission tomography in Parkinson's disease.
Topics: Deoxyglucose; Dopamine; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Tomography, Emission-Computed | 1992 |
Neural mechanisms in disorders of movement.
Topics: Animals; Autoradiography; Basal Ganglia; Biomechanical Phenomena; Brain; Chorea; Deoxyglucose; Hyperkinesis; Movement Disorders; Parkinson Disease | 1989 |
Positron emission tomography imaging of regional cerebral glucose metabolism.
Topics: Aging; Brain; Brain Diseases; Brain Neoplasms; Central Nervous System Diseases; Cerebrovascular Disorders; Dementia; Deoxyglucose; Epilepsy; Fluorodeoxyglucose F18; Glucose; Humans; Huntington Disease; Parkinson Disease; Radiography; Schizophrenia; Tissue Distribution; Tomography, Emission-Computed | 1986 |
Cerebral glucose and dopa metabolism in movement disorders.
Topics: Animals; Brain; Deoxy Sugars; Deoxyglucose; Dihydroxyphenylalanine; Humans; Huntington Disease; Parkinson Disease; Tomography, Emission-Computed | 1987 |
43 other study(ies) available for deoxyglucose and Parkinson Disease
Article | Year |
---|---|
Lewy Body Disease Primate Model with α-Synuclein Propagation from the Olfactory Bulb.
Topics: alpha-Synuclein; Animals; Callithrix; Deoxyglucose; Glucose; Lewy Body Disease; Manganese; Olfactory Bulb; Parkinson Disease | 2022 |
Inhibiting Lateral Habenula Improves L-DOPA-Induced Dyskinesia.
Topics: Animals; Corpus Striatum; Daunorubicin; Deoxyglucose; Disease Models, Animal; Dyskinesia, Drug-Induced; Electrophysiology; Female; Genes, Immediate-Early; Habenula; Levodopa; Macaca fascicularis; Male; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley | 2016 |
MicroRNA-7 Promotes Glycolysis to Protect against 1-Methyl-4-phenylpyridinium-induced Cell Death.
Topics: 1-Methyl-4-phenylpyridinium; Adenosine Triphosphate; Animals; Cell Death; Cell Differentiation; Cell Line, Tumor; Cell Survival; Deoxyglucose; Glucose; Glucose Transporter Type 3; Glycolysis; HEK293 Cells; Humans; Lactic Acid; Mice; Mice, Inbred C57BL; MicroRNAs; Mitochondria; Neurons; Oxidative Phosphorylation; Oxygen; Parkinson Disease; Phosphorylation; Transcription Factor RelA | 2015 |
Inhibition of platelet aggregation by 1-methyl-4-phenyl pyridinium ion (MPP+) through ATP depletion: Evidence for the reduced platelet activities in Parkinson's disease.
Topics: 1-Methyl-4-phenylpyridinium; Adenosine Triphosphate; Animals; Blood Platelets; Calcium; Cell Survival; Collagen; Deoxyglucose; Glutathione; In Vitro Techniques; Parkinson Disease; Platelet Aggregation; Rats; Rats, Sprague-Dawley | 2009 |
Plasma and urinary HPLC-ED determination of the ratio of 8-OHdG/2-dG in Parkinson's disease.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Aged, 80 and over; Antiparkinson Agents; Biomarkers; Case-Control Studies; Chromatography, High Pressure Liquid; Deoxyglucose; Deoxyguanosine; DNA Damage; DNA Repair; Electrochemical Techniques; Female; Humans; Levodopa; Male; Middle Aged; Oxidative Stress; Parkinson Disease | 2011 |
Mitochondrial translocation of alpha-synuclein is promoted by intracellular acidification.
Topics: alpha-Synuclein; Antimetabolites; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cell Line; Deoxyglucose; Enzyme Inhibitors; Humans; Hydrogen Peroxide; Hydrogen-Ion Concentration; Mitochondria; Mitochondrial Membranes; Oxidants; Oxidative Stress; Parkinson Disease; Protein Binding; Protein Transport; Sodium Azide; Uncoupling Agents | 2008 |
Imaging CNS receptors: the dopaminergic system.
Topics: Animals; Antipsychotic Agents; Apomorphine; Binding Sites; Brain; Carbon Radioisotopes; Deoxyglucose; Dyskinesia, Drug-Induced; Fluorine; Haloperidol; Humans; Parkinson Disease; Radioisotopes; Receptors, Dopamine; Schizophrenia; Spiperone; Tomography, Emission-Computed; Tritium | 1984 |
Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease.
Topics: Adolescent; Adult; Aged; Brain; Caudate Nucleus; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Huntington Disease; Middle Aged; Parkinson Disease; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1984 |
Cerebral metabolic relationships for selected brain regions in Alzheimer's, Huntington's, and Parkinson's diseases.
Topics: Aged; Alzheimer Disease; Cerebral Cortex; Deoxyglucose; Fluorine; Humans; Huntington Disease; Middle Aged; Parkinson Disease; Radioisotopes | 1984 |
Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease.
Topics: Antiparkinson Agents; Autoradiography; Blood Glucose; Brain; Deoxyglucose; Drug Therapy, Combination; Fluorodeoxyglucose F18; Humans; Kinetics; Levodopa; Male; Middle Aged; Parkinson Disease; Tomography, Emission-Computed | 1984 |
Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method.
Topics: Aged; Brain; Dementia; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Middle Aged; Parkinson Disease; Tomography, Emission-Computed | 1984 |
Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.
Topics: Adult; Aged; Carbon Radioisotopes; Caudate Nucleus; Corpus Striatum; Deoxyglucose; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine; Dopamine Antagonists; Energy Metabolism; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Parkinson Disease; Putamen; Raclopride; Receptors, Dopamine D2; Salicylamides; Tomography, Emission-Computed | 1995 |
Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography.
Topics: Adult; Aged; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinson Disease; Tomography, Emission-Computed | 1995 |
Clinical/metabolic correlations in multiple system atrophy. A fludeoxyglucose F 18 positron emission tomographic study.
Topics: Atrophy; Brain Diseases; Corpus Striatum; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Levodopa; Male; Middle Aged; Olivopontocerebellar Atrophies; Parkinson Disease; Substantia Nigra; Tomography, Emission-Computed | 1995 |
Assessment of disease severity in parkinsonism with fluorine-18-fluorodeoxyglucose and PET.
Topics: Adult; Aged; Brain; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Tomography, Emission-Computed | 1995 |
Metabolic topography of the hemiparkinsonism-hemiatrophy syndrome.
Topics: Adult; Atrophy; Brain; Deoxyglucose; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Parkinson Disease; Syndrome; Tomography, Emission-Computed | 1994 |
[What is the connection between Parkinson disease and tardive dyskinesia?].
Topics: Animals; Antipsychotic Agents; Deoxyglucose; Dyskinesia, Drug-Induced; gamma-Aminobutyric Acid; Haplorhini; Humans; Models, Biological; Parkinson Disease; Receptors, Dopamine | 1994 |
Positron emission tomography in hemiparkinsonism-hemiatrophy syndrome.
Topics: Adult; Aged; Atrophy; Blood Glucose; Brain; Deoxyglucose; Dominance, Cerebral; Energy Metabolism; Facial Hemiatrophy; Female; Fluorodeoxyglucose F18; Hemiplegia; Humans; Middle Aged; Neurologic Examination; Parkinson Disease; Tomography, Emission-Computed | 1993 |
Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease.
Topics: Aged; Brain; Corpus Striatum; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Kinetics; Male; Middle Aged; Organ Specificity; Parkinson Disease; Reference Values; Substantia Nigra; Tomography, Emission-Computed | 1993 |
Regional metabolic correlates of surgical outcome following unilateral pallidotomy for Parkinson's disease.
Topics: Aged; Brain; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Globus Pallidus; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Tissue Distribution; Tomography, Emission-Computed; Treatment Outcome | 1996 |
The metabolic topography of normal aging.
Topics: Adult; Aged; Aged, 80 and over; Aging; Brain; Brain Mapping; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Models, Neurological; Parkinson Disease; Reference Values; Regression Analysis; Tomography, Emission-Computed | 1996 |
Parkinsonian rigidity, dopa-induced dyskinesia and chorea--dynamic studies on the basal ganglia-thalamocortical motor circuit using PET scan and depth microrecording.
Topics: Antiparkinson Agents; Basal Ganglia; Blood Glucose; Brain; Brain Mapping; Cerebral Cortex; Chorea; Deoxyglucose; Dyskinesia, Drug-Induced; Electrodes, Implanted; Energy Metabolism; Fluorodeoxyglucose F18; Globus Pallidus; Humans; Levodopa; Motor Neurons; Neural Pathways; Neurologic Examination; Parkinson Disease; Stereotaxic Techniques; Thalamic Nuclei; Tomography, Emission-Computed; Tremor | 1995 |
Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease.
Topics: Aged; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Middle Aged; Parkinson Disease; Prospective Studies; Tomography, Emission-Computed | 1996 |
Secondary parkinsonism due to focal substantia nigra lesions: a PET study with [18F]FDG and [18F]fluorodopa.
Topics: Aged; Deoxyglucose; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Parkinson Disease; Substantia Nigra; Tomography, Emission-Computed | 1996 |
[A case of familial juvenile dystonia-parkinsonism: 18F-6-fluorodopa and 18F-fluoro-2-deoxyglucose PET study].
Topics: Adult; Age of Onset; Brain; Deoxyglucose; Dihydroxyphenylalanine; Dystonia; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Levodopa; Parkinson Disease; Tomography, Emission-Computed | 1996 |
Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease.
Topics: Adult; Aged; Biological Transport; Brain; Case-Control Studies; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Hexokinase; Humans; Male; Models, Theoretical; Parkinson Disease; Tomography, Emission-Computed | 1996 |
Regional changes in [18F]dopa metabolism in the striatum in Parkinson's disease.
Topics: Deoxyglucose; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Middle Aged; Parkinson Disease; Putamen; Tomography, Emission-Computed | 1996 |
Functional effects of striatal dysfunction in Parkinson disease.
Topics: Aged; Basal Ganglia; Corpus Striatum; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Memory; Middle Aged; Movement; Parkinson Disease; Radionuclide Imaging | 1997 |
Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
Topics: Aged; Alzheimer Disease; Brain; Brain Mapping; Case-Control Studies; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Neuropsychological Tests; Parkinson Disease; Stereotaxic Techniques; Tomography, Emission-Computed | 1997 |
Structures outside the basal ganglia may compensate for dopamine loss in the presymptomatic stages of Parkinson's disease.
Topics: Animals; Basal Ganglia; Deoxyglucose; Disease Models, Animal; Dopamine; Haplorhini; Motor Activity; Parkinson Disease; Thalamic Nuclei | 2001 |
Regional cerebral glucose metabolism in patients with Parkinson's disease with or without dementia.
Topics: Aged; Brain; Dementia; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Parkinson Disease; Tomography, Emission-Computed | 1992 |
Hemi-parkinsonism in multiple system atrophy: a PET and MRI study.
Topics: Adult; Aged; Atrophy; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organ Specificity; Parkinson Disease; Reference Values; Tomography, Emission-Computed | 1992 |
Positron emission tomography in degenerative disorders of the dopaminergic system.
Topics: Adult; Aged; Alzheimer Disease; Basal Ganglia; Brain; Brain Stem; Deoxyglucose; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Middle Aged; Parietal Lobe; Parkinson Disease; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 1992 |
A 2-deoxyglucose study of the effects of dopamine agonists on the parkinsonian primate brain. Implications for the neural mechanisms that mediate dopamine agonist-induced dyskinesia.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Deoxyglucose; Female; Globus Pallidus; Levodopa; Macaca fascicularis; Male; Parkinson Disease; Thalamic Nuclei | 1992 |
A regional covariance approach to the analysis of functional patterns in positron emission tomographic data.
Topics: AIDS Dementia Complex; Analysis of Variance; Brain; Brain Diseases; Cerebellar Diseases; Data Interpretation, Statistical; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Kinetics; Mathematics; Paraneoplastic Syndromes; Parkinson Disease; Tomography, Emission-Computed | 1991 |
The metabolic anatomy of Parkinson's disease: complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies.
Topics: Adult; Brain; Deoxy Sugars; Deoxyglucose; Dihydroxyphenylalanine; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinson Disease; Tomography, Emission-Computed | 1990 |
[Positron emission tomography and basal ganglia functions].
Topics: Animals; Basal Ganglia; Basal Ganglia Diseases; Corpus Striatum; Deoxyglucose; Dopamine; Energy Metabolism; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Macaca mulatta; Mice; Parkinson Disease; Rats; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 1990 |
Brain glucose metabolism in Parkinson's disease.
Topics: Aged; Blood Glucose; Brain; Brain Mapping; Dementia; Deoxyglucose; Energy Metabolism; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Tomography, Emission-Computed | 1990 |
The role of striatopallidal neurones utilizing gamma-aminobutyric acid in the pathophysiology of MPTP-induced parkinsonism in the primate: evidence from [3H]flunitrazepam autoradiography.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Brain; Carbidopa; Corpus Striatum; Deoxyglucose; Flunitrazepam; gamma-Aminobutyric Acid; Globus Pallidus; Levodopa; Macaca fascicularis; Neurons; Organ Specificity; Parkinson Disease; Parkinson Disease, Secondary; Tritium | 1990 |
[Comparison study of positron emission tomography, X-ray CT and MRI in parkinsonism with dementia].
Topics: Aged; Aged, 80 and over; Brain; Dementia; Deoxy Sugars; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Parkinson Disease; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1989 |
Positron emission tomography in Parkinson's disease: glucose and DOPA metabolism.
Topics: Adult; Aged; Blood Glucose; Brain; Caudate Nucleus; Cerebellum; Deoxyglucose; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Levodopa; Middle Aged; Parkinson Disease; Putamen; Tomography, Emission-Computed | 1987 |
Local cerebral glucose utilization in symptomatic and presymptomatic Huntington's disease.
Topics: Adolescent; Adult; Alzheimer Disease; Brain; Caudate Nucleus; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Huntington Disease; Middle Aged; Parkinson Disease; Putamen; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1985 |
Metabolic aspects of aging brain and related disorders.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aging; Alzheimer Disease; Animals; Brain; Cerebral Cortex; Deoxy Sugars; Deoxyglucose; Humans; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred C57BL; Parkinson Disease; Pyridines; Rats; Rats, Inbred Strains; Superoxide Dismutase; Tomography, Emission-Computed | 1987 |